Table of Contents
1. Executive Summary
2. Global Migraine Drugs Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2017 to 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Migraine Drugs Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Migraine Drugs Market by Product Type
3.3.1: Acute Migraine Treatment
3.3.2: Preventive Migraine Treatment
3.4: Global Migraine Drugs Market by Route of Administration
3.4.1: Oral
3.4.2: Injectables
3.4.3: Others
3.5: Global Migraine Drugs Market by Distribution Channel
3.5.1: Hospital Pharmacies
3.5.2: Retail Pharmacies
3.5.3: Online Pharmacies
4. Market Trends and Forecast Analysis by Region from 2017 to 2028
4.1: Global Migraine Drugs Market by Region
4.2: North American Migraine Drugs Market
4.2.1: North American Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.2.2: North American Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.3: European Migraine Drugs Market
4.3.1: European Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.3.2: European Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.4: APAC Migraine Drugs Market
4.4.1: APAC Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.4.2: APAC Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.5: ROW Migraine Drugs Market
4.5.1: ROW Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.5.2: ROW Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
5. Competitor Analysis
5.1: Product Type Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Migraine Drugs Market by Product Type
6.1.2: Growth Opportunities for the Global Migraine Drugs Market by Route of Administration
6.1.3: Growth Opportunities for the Global Migraine Drugs Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Migraine Drugs Market by Region
6.2: Emerging Trends in the Global Migraine Drugs Market
6.3: Strategic Analysis
6.3.1: New Product Type Development
6.3.2: Capacity Expansion of the Global Migraine Drugs Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Migraine Drugs Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Allergan
7.2: Abbott Laboratories
7.3: AstraZeneca
7.4: Endo International
7.5: Eisai
7.6: Impax Laboratories
7.7: GlaxoSmithKline
7.8: Johnson & Johnson
7.9: Pfizer
7.9: Merck & Co.
7.10: Sanofi SA